Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 1999 Dec;65(6):1776-9.
doi: 10.1086/302675.

The importance of a family history of breast cancer in predicting the presence of a BRCA mutation

W D Foulkes, J S Brunet, E Warner, P J Goodwin, W Meschino, S A Narod, P E Goss, G Glendon
Comment

The importance of a family history of breast cancer in predicting the presence of a BRCA mutation

W D Foulkes et al. Am J Hum Genet. 1999 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

Electronic-Database Information

    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim (for BRCA1 [MIM 113705] and for BRCA2 [MIM 600185])

References

    1. Fodor FH, Weston A, Bleiweiss IJ, McCurdy LD, Walsh MM, Tartter PI, Brower ST, et al (1998) Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet 63:45–51 - PMC - PubMed
    1. Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64:963–970 - PMC - PubMed
    1. Karp SE, Tonin PN, Bégin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD (1997) Influence of BRCA1 mutations on nuclear grade and estrogen receptor status on breast carcinoma in Ashkenazi Jewish women. Cancer 80:435–441 - PubMed
    1. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA 278:1242–1250 - PubMed
    1. Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Patterson C, Ozcelik H, et al (1999) Prevalence and penetrance of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241–1247 - PubMed